Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Severe hypophosphatemia after intravenous administration of iron carboxymaltose in a stable renal transplant recipient.

× No keyword cloud information.

11 in total

1. Severe and prolonged hypophosphatemia after intravenous iron administration in a malnourished patient.

Authors: Y C Fierz; R Kenmeni; A Gonthier; F Lier; F Pralong; P Coti Bertrand
Journal: Eur J Clin Nutr Date: 2014-02-26 Impact factor: 4.016

Review 2. Single-dose intravenous iron for iron deficiency: a new paradigm.

Authors: Michael Auerbach; Thomas Deloughery
Journal: Hematology Am Soc Hematol Educ Program Date: 2016-12-02

3. Effects of ferric carboxymaltose on markers of mineral and bone metabolism: A single-center prospective observational study of women with iron deficiency.

Authors: Rebecca Frazier; Alexander Hodakowski; Xuan Cai; Jungwha Lee; Anaadriana Zakarija; Brady Stein; Valentin David; Myles Wolf; Tamara Isakova; Rupal Mehta
Journal: Bone Date: 2020-07-28 Impact factor: 4.398

4. Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials.

Authors: Charles F Barish; Todd Koch; Angelia Butcher; David Morris; David B Bregman
Journal: Anemia Date: 2012-09-10

Review 5. Intravenous iron administration and hypophosphatemia in clinical practice.

Authors: S Hardy; X Vandemergel
Journal: Int J Rheumatol Date: 2015-04-27

6. Potentially life-threatening phosphate diabetes induced by ferric carboxymaltose injection: a case report and review of the literature.

Authors: Xavier Vandemergel; Frédéric Vandergheynst
Journal: Case Rep Endocrinol Date: 2014-11-13

7. Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk.

Authors: Benedikt Schaefer; Philipp Würtinger; Armin Finkenstedt; Vickie Braithwaite; André Viveiros; Maria Effenberger; Irene Sulzbacher; Alexander Moschen; Andrea Griesmacher; Herbert Tilg; Wolfgang Vogel; Heinz Zoller
Journal: PLoS One Date: 2016-12-01 Impact factor: 3.240

8. Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions.

Authors: N Franklin Adkinson; William E Strauss; Kristine Bernard; Robert F Kaper; Iain C Macdougall; Julie S Krop
Journal: J Blood Med Date: 2017-09-26

Review 9. Hypophosphatemia Associated with Intravenous Iron Therapies for Iron Deficiency Anemia: A Systematic Literature Review.

Authors: John A Glaspy; Michelle Z Lim-Watson; Michael A Libre; Swagata S Karkare; Nandini Hadker; Aleksandra Bajic-Lucas; William E Strauss; Naomi V Dahl
Journal: Ther Clin Risk Manag Date: 2020-04-08 Impact factor: 2.423

10. Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial.

Authors: N Franklin Adkinson; William E Strauss; Iain C Macdougall; Kristine E Bernard; Michael Auerbach; Robert F Kaper; Glenn M Chertow; Julie S Krop
Journal: Am J Hematol Date: 2018-02-24 Impact factor: 10.047